Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center

Acute hematogenous osteomyelitis (AHOM) is a rare pathology in pediatric population. The aim of this study is to analyse the epidemiological data and the management, compared to European Society for Paediatric Infectious Disease (ESPID, European Society for Pediatric Infectious Diseases) guidelines...

Full description

Bibliographic Details
Main Authors: Paola Musso, Sara Parigi, Grazia Bossi, Gian Luigi Marseglia, Luisa Galli, Elena Chiappini
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/8/8/616
id doaj-fe9ff2f6df8f4e4d8f18d1a982080f3f
record_format Article
spelling doaj-fe9ff2f6df8f4e4d8f18d1a982080f3f2021-08-26T13:38:05ZengMDPI AGChildren2227-90672021-07-01861661610.3390/children8080616Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric CenterPaola Musso0Sara Parigi1Grazia Bossi2Gian Luigi Marseglia3Luisa Galli4Elena Chiappini5Pediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, ItalyDepartment of Health Sciences, University of Florence, 50100 Florence, ItalyPediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, ItalyPediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, ItalyDepartment of Health Sciences, University of Florence, 50100 Florence, ItalyDepartment of Health Sciences, University of Florence, 50100 Florence, ItalyAcute hematogenous osteomyelitis (AHOM) is a rare pathology in pediatric population. The aim of this study is to analyse the epidemiological data and the management, compared to European Society for Paediatric Infectious Disease (ESPID, European Society for Pediatric Infectious Diseases) guidelines 2017 of 216 children with AHOM, divided in three cohorts (neonatal-onset osteomyelitis, those with vertebral involvement and other types of osteomyelitis). We conducted a retrospective single center study, evaluating data from all the children (aged 0–18 years) consecutively admitted to the Meyer Children’s Hospital, during a period of ten years (1 January 2010–31 December 2019). Isolation of pathogen was possible in 65 patients and <i>S. aureus</i> was the most frequently involved (43/65 children). Magnetic Resonance Imaging (MRI, magnetic resonance imaging) was performed in 201/216 cases and was compatible with osteomyelitis in 185/201 of these children (92.03%). In the neonatal-onset osteomyelitis group the percentage of diagnostic ultrasound for osteomyelitis was 36.36% significantly higher than the other groups. The median duration of total antibiotic therapy was 37.5 days. In total, 186/199 children recovered without complications. The present study delineates three heterogeneous cohorts of patients. <i>S. aureus</i> is confirmed as the first pathogen for isolation in all three groups analysed. MRI represent a gold standard for diagnosis. Longer duration of antibiotics treatment was performed in neonatal and spondylodiscitis group, compared to the other types of osteomyelitis.https://www.mdpi.com/2227-9067/8/8/616osteomyelitisspondylodiscitisnewbornbone infectionchildren
collection DOAJ
language English
format Article
sources DOAJ
author Paola Musso
Sara Parigi
Grazia Bossi
Gian Luigi Marseglia
Luisa Galli
Elena Chiappini
spellingShingle Paola Musso
Sara Parigi
Grazia Bossi
Gian Luigi Marseglia
Luisa Galli
Elena Chiappini
Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
Children
osteomyelitis
spondylodiscitis
newborn
bone infection
children
author_facet Paola Musso
Sara Parigi
Grazia Bossi
Gian Luigi Marseglia
Luisa Galli
Elena Chiappini
author_sort Paola Musso
title Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
title_short Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
title_full Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
title_fullStr Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
title_full_unstemmed Epidemiology and Management of Acute Hematogenous Osteomyelitis, Neonatal Osteomyelitis and Spondylodiscitis in a Third Level Paediatric Center
title_sort epidemiology and management of acute hematogenous osteomyelitis, neonatal osteomyelitis and spondylodiscitis in a third level paediatric center
publisher MDPI AG
series Children
issn 2227-9067
publishDate 2021-07-01
description Acute hematogenous osteomyelitis (AHOM) is a rare pathology in pediatric population. The aim of this study is to analyse the epidemiological data and the management, compared to European Society for Paediatric Infectious Disease (ESPID, European Society for Pediatric Infectious Diseases) guidelines 2017 of 216 children with AHOM, divided in three cohorts (neonatal-onset osteomyelitis, those with vertebral involvement and other types of osteomyelitis). We conducted a retrospective single center study, evaluating data from all the children (aged 0–18 years) consecutively admitted to the Meyer Children’s Hospital, during a period of ten years (1 January 2010–31 December 2019). Isolation of pathogen was possible in 65 patients and <i>S. aureus</i> was the most frequently involved (43/65 children). Magnetic Resonance Imaging (MRI, magnetic resonance imaging) was performed in 201/216 cases and was compatible with osteomyelitis in 185/201 of these children (92.03%). In the neonatal-onset osteomyelitis group the percentage of diagnostic ultrasound for osteomyelitis was 36.36% significantly higher than the other groups. The median duration of total antibiotic therapy was 37.5 days. In total, 186/199 children recovered without complications. The present study delineates three heterogeneous cohorts of patients. <i>S. aureus</i> is confirmed as the first pathogen for isolation in all three groups analysed. MRI represent a gold standard for diagnosis. Longer duration of antibiotics treatment was performed in neonatal and spondylodiscitis group, compared to the other types of osteomyelitis.
topic osteomyelitis
spondylodiscitis
newborn
bone infection
children
url https://www.mdpi.com/2227-9067/8/8/616
work_keys_str_mv AT paolamusso epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
AT saraparigi epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
AT graziabossi epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
AT gianluigimarseglia epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
AT luisagalli epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
AT elenachiappini epidemiologyandmanagementofacutehematogenousosteomyelitisneonatalosteomyelitisandspondylodiscitisinathirdlevelpaediatriccenter
_version_ 1721194317620445184